LATEST: ⚡️ Brian Armstrong's anti-aging biotech Newlimit raised $435M in a Series C, tripling its valuation to $3.1B, and plans to start human trials next year. https://t.co/GPmRm6UBMV
Jun 3, 2026
Views28.6k
Comments42
Reposts48
LATEST: ⚡️ Brian Armstrong's anti-aging biotech Newlimit raised $435M in a Series C, tripling its valuation to $3.1B, and plans to start human trials next year. https://t.co/GPmRm6UBMV
Latest launch Jun 3, 2026Browse lists